Digital Respiratory Devices Market Size, Share, By Product (Smart Inhalers, Nebulizers Sensors, and Apps), Indication (Sleep Apnea, Chronic Obstructive Pulmonary Disease (COPD), Asthma, and Infectious Diseases), End-User (Hospitals, Homecare Settings, and Others), and Region - Trends, Analysis, and Forecast till 2035
A digital respiratory device is a medical device that uses technology to monitor and manage respiratory condition, such as asthma, COPD and other disorders. The increasing demand for the diagnosis and treatment rate for the respiratory disorders and technological advancements is expected to drive digital respiratory devices market growth.
Digital Respiratory Devices Market Report Highlights:
- By 2035, the target market is expected to increase at a rate of USD 553.3 Billion.
- In 2024, the digital respiratory devices market size was valued at USD 57.48 Billion.
- The market is expanding at a CAGR of 25.6%.
- North America is the leading region in the digital respiratory devices market.
- Asia Pacific is projected to be the fastest-growing region in the market.
- On the basis of product, the leading segment in the market is the small inhalers segment.
- By indication, the chronic obstructive pulmonary disease segment holds the digital respiratory devices market.
- Under end-user, the market is led by the hospitals segment.
Key Benefits of Purchasing This Report
Gain valuable insights into revenue projections for the overall market and its sub-segments, benefiting industry leaders and new entrants.
Enhance your understanding of the competitive landscape to refine business positioning and optimize go-to-market strategies.
Stay informed on the latest trends in the Digital Respiratory Devices Market, including key drivers, challenges, opportunities, and barriers.
Digital Respiratory Devices Market Key Highlights:
In October 2024, Honeywell announced long-term supply agreement with DevPro Biopharma to develop a respiratory inhaler to enhance the well-being of patients and reduce carbon emissions associated with traditional inhalers. The Honeywell Solstice Air HFO-1234ze technology designed to treat patients with asthma and COPD diseases. The albuterol inhaler designed to reduce environmental impact by maintaining its efficacy in treating respiratory conditions.
Segmentation:
By Product:
- Smart Inhalers
- Nebulizers Sensors & Apps
By Indication:
- Sleep Apnea
- Chronic Obstructive Pulmonary Disease (COPD)
- Asthma
- Infectious diseases
By End-User:
- Hospitals
- Homecare Settings
- Other Settings.
By Region:
- North America
- U.S.
- Canada
- Europe
- Germany
- U.K.
- France
- Russia
- Italy
- Spain
- Netherlands
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- Indonesia
- Malaysia
- South Korea
- Rest of Asia Pacific
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Middle East & Africa
- GCC
- Israel
- South Africa
- Rest of Middle East & Africa
Digital Respiratory Devices Market Competitive Landscape
- Amiko Digital Health Limited
- Cognita Labs
- AptarGroup, Inc.
- Adherium
- Teva Pharmaceutical Industries Ltd.
- 3M
- Sensiron AG
- Fisher & Paykel Healthcare Limited
- Welch Allyn, Inc.
- Propeller Health
- Koninklijke Philips N.V.
- Stryker
- Trivitron Healthcare
Key Questions Answered in This Report
1. What was the size of the Digital Respiratory Devices Market in 2024?
2. What is the expected growth rate of the Digital Respiratory Devices Market during 2025-2035?
3. What are the key factors driving the Digital Respiratory Devices Market?
4. What is the breakup of the Digital Respiratory Devices Market based on the distribution channel?
5. What are the key regions in the Digital Respiratory Devices Market?
6. Who are the key players/companies in the Digital Respiratory Devices Market?
7. What are the drivers, restraints, and opportunities in the Digital Respiratory Devices Market?